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Highlights 
  T2 mapping has significantly outperforms normalised FLAIR in differentiating sclerotic from 
healthy hippocampi 
  Due to high sensitivity and specificity T2 mapping carries high potential to point out potential 
bilateral pathology 
  The difference of ability to detect the pathology by the two techniques is likely to hold for 
advanced FLAIR sequences 
  T2 mapping should be the technique of choice to differentiate hippocampal sclerosis in clinical 
setting 
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Abstract 
Rationale: Qualitatively, FLAIR MR imaging is sensitive to the detection of hippocampal sclerosis (HS). 
Quantitative analysis of T2 maps provides a useful objective measure and increased sensitivity over 
visual inspection of T2-weighted scans.  We aimed to determine whether quantification of normalised 
FLAIR is as sensitive as T2 mapping in detection of HS. 
Method: Dual echo T2 and FLAIR MR images were retrospectively analysed in 27 patients with 
histologically confirmed HS and increased T2 signal in ipsilateral hippocampus and 14 healthy controls. 
Regions of interest were manually segmented in all hippocampi aiming to avoid inclusion of CSF. 
Hippocampal T2 values and measures of normalised FLAIR Signal Intensity (nFSI) were compared in 
healthy and sclerotic hippocampi. 
Results: HS was identified on T2 values with 100% sensitivity and 100% specificity. HS was identified 
on nFSI measures with 60% sensitivity and 93% specificity. 
Conclusion: T2 mapping is superior to nFSI for identification of HS. 
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Introduction 
Increased signal intensity on T2 weighted MR images is one of the diagnostic criteria for hippocampal 
sclerosis (HS) [Cendes F, 2013]. FLAIR MR imaging is a popular and sensitive method for identifying 
cerebral parenchymal abnormalities, including HS [Duncan JS, 2010]. 
Quantification of hippocampal T2 signal is useful as an objective measure of hippocampal pathology 
[Woermann FG, et al, 1998] that is useful for research purposes and clinically, both to identify subtle 
abnormalities and to determine if the contralateral hippocampus is normal when hippocampal 
resection is planned for treatment of epilepsy.  
Hippocampal T2 mapping has been used to good effect for many years, and can be estimated using a 
dual echo sequence [Bartlett PA, et al, 2007]. It would be advantageous if quantification of FLAIR 
signal would achieve these aims, as the sequence is routinely acquired clinically. Mapping of 
normalised FLAIR signal intensity (nFSI) has been shown to be sensitive to detection of malformations 
of cortical development and also assists the detection of subtle cortical lesions [Focke NK, et al, 2008, 
2009]. In one study, mapping hippocampal FLAIR signal intensity [Huppertz H-J, et al, 2011] showed 
good separation between patients with HS and healthy controls.  
We aimed to check if normalised FLAIR technique is as sensitive and specific as clinically validated T2 
mapping technique in the task of the detection of HS. 
Method 
Subjects 
We analysed MRI data from three cohorts of subjects, comprising patients with histologically 
confirmed right (13) HS, left (14) HS and elevated T2 values measured in vivo with a dual echo method 
[Bartlett PA, et al, 2007], and 14 healthy controls. The median (range) of age of the controls was 44 
(24-61) years. The histological analysis of hippocampal tissue removed during the resective surgery 
confirmed HS in all patients with two left HS patients having triple and dual pathology (1 - HS, focal 
cortical dysplasia, ganglioglioma; 2 - HS, dysembryoplastic neuroepithelial tumour). The characteristics 
of the patient group are summarized in Table 1. 
 
The patients were scanned for clinical purposes using the established clinical protocol that included T2 
FLAIR and dual T2 images. The Research Ethics Committee did not require individual patient consent 
as the study was classified as a service evaluation. The HS was diagnosed preoperatively on MRI of all 
patients and confirmed histologically. Healthy controls gave written, informed consent. 
Imaging 
The images utilised for the analysis were acquired on a GE Excite 3T MRI scanner with an 8-channel 
head coil. 
T2 Fluid Attenuated Inversion Recovery (FLAIR): Fast Spin Echo (FSE), TE 140ms, TR 11000ms, TI 2250, 
NEX=1, FOV 24x24 cm, 32 slices, 256x256 matrix size, voxel size 0.94x0.94x5 mm, scan duration 2 min 
57 sec. ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT
Dual-echo T2 mapping: Fast Relaxation Fast Spin Echo (FRFSE), TR 2000ms, TE 30 and 80ms, FOV 
24x24cm, 32 slices, 256x256 matrix size; voxel size 0.94x0.94x5 mm, scan duration 3 min 1 sec. 
Both scans were oriented in the oblique coronal plane in the same axis as the brain stem, orthogonal 
to the hippocampus, so as to minimize partial volume effects (Figure 1). 
 
Data Analysis 
 
Pixel-by-pixel T2 maps were calculated from the FRFSE images by using the expression T2 = (TE2-
TE1)/[ln(S1/S2)], where S1 and S2 are the signal intensity in the early- and late-echo images, with echo 
times TE1=30ms and TE2=80ms, respectively. [Bartlett PA, et al, 2007] 
An ovoid hippocampal region of interest (ROI) was placed manually within the hippocampus both on 
FLAIR and T2 map images, in 4-5 consecutive 5mm thick coronal slices from posterior to anterior. The 
ROI was at least 18 mm2 and as large as could be accommodated within the outline of the 
hippocampus while avoiding CSF and partial volume effect with CSF. The T2 map and T2 FLAIR images 
were arranged on the screen next to each other in the process of segmentation (Figure 1), to ensure 
that the ROIs were placed in the same parts of the two series of scans. 
The average signal intensities were measured across each coronal slice of each hippocampal ROI of 
both T2 FLAIR and T2 images. The data from each individual slice were averaged to yield a single 
measure for each hippocampus. 
The hippocampal ROI measures obtained from the T2 FLAIR were normalised using the average T2 
FLAIR signal intensity across white matter in pons and anterior frontal lobes as described previously 
for nFSI analysis [Focke NK, et al, 2008, 2009]. The nFSI image processing was implemented using FSL 
(FMRIB, Oxford, UK). 
 
Results 
 
Figure 2 illustrates the comparison of separation between normal (controls; 28) and diseased 
(histologically confirmed HS in patients; 27) hippocampi based on T2 (horizontal axis) and nFSI (vertical 
axis) values. The upper limit of normal hippocampal T2 in this cohort, defined as mean + 2SDs, was 109 
ms with one normal hippocampus on the borderline (108.8ms). Sclerotic hippocampi had T2 values 
ranging from 109.4 ms to 124.4 ms with one of them very close to the normal limit. 
The upper limit of normal of nFSI, defined as mean + 2SDs, was 1683 normalised units. The nFSI of one 
control has reached 1750 n.u. exceeding the normal limit. 11/27 sclerotic hippocampi had nFSI values 
below the normal limit with one very close to the borderline (1680 n.u.). 
 
Figure 3 demonstrates the ability of lateralisation of HS and separation between healthy controls and 
patients for each imaging technique individually (a – T2 mapping; b - nFSI). Note the possibility to draw ACCEPTED MANUSCRIPT
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the separating limits on a T2 values (Figure 3a) plot in a way which allows avoiding both false positives 
and negatives. 
The healthy hippocampi were differentiated from sclerotic hippocampi proved histologically based on: 
-  T2 values: 100% sensitivity and 100% specificity; 
-  nFSI values: 60% sensitivity and 93% specificity, 
where specificity and sensitivity were calculated based on the thresholds shown on Figure 3 (Campbell 
MJ, et al, 2007). 
As expected, in some patients the hippocampus contralateral to HS had abnormal T2 values in 6/27 
(22%) cases (Figure 2), reflecting the fact that HS may be bilateral. 
Discussion 
 
We compared the sensitivity and specificity of normalised FLAIR and T2 mapping techniques in the 
task of the detection of HS based on the cohort of patients with histologically confirmed HS and 
elevated T2 signal in the ipsilateral hippocampus. 
The results demonstrate a higher rate of differentiation between healthy and sclerotic hippocampi 
when using dual-echo T2 mapping technique compared to nFSI. 
We applied the same method of analysis for images of both sequences in order to concentrate on 
comparison of the imaging techniques rather than the specificities of the analysis. The only difference 
- the step of normalisation of the T2 FLAIR image – was unavoidable as the FLAIR image is not 
quantitative. 
The accurate segmentation of hippocampal ROI is crucial for this study. Despite the recent significant 
advances in automated segmentation of hippocampi [Winston GP, et al, 2013] the manual 
segmentation of sclerotic hippocampi with emphasis on morphology remains the gold standard. 
Manual placement of an ovoid hippocampal ROI allowed avoiding inclusion of high T2 signal from CSF 
around hippocampus. The choroid plexus may give rise to false positive high signal when erroneously 
segmenting posterior section of hippocampus. 
Therefore, our choice of the analysis algorithm was predefined by the method of manual 
segmentation and the technique which has been successfully used in clinical practice [Bartlett PA, et 
al, 2007]. 
The two cases with additional pathology (1 - HS, focal cortical dysplasia, ganglioglioma; 2 - HS, 
dysembryoplastic neuroepithelial tumour) were the only left HS cases showing weak evidence for 
bilateral HS according to the T2 mapping results (the 2 red labels above the horizontal threshold line 
on the Figure 3A). The separation from controls based on nFSI was successful in one of these two 
cases. These results do not show difference from the results observed in cases of single pathology 
when the measurements taken from the resected hippocampi are considered. 
The different nFSI algorithm has been successfully applied for the differentiation of controls from 
patients with HS [Huppertz H-J, et al, 2011]. The authors reported 97% sensitivity with 95% specificity ACCEPTED MANUSCRIPT
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for the differentiation of controls from patients with 95% confidence. The significant difference from 
our result can be related to the differences in the analysis algorithms of which the key are the 
definition of ROI, FLAIR image normalisation, approach to set up statistical limits between controls and 
patients. The ROI in our study are significantly smaller due to the necessity to avoid partial volume 
effects with CSF appearing as high signal on T2 images. In addition, any approaches based on applying 
masks of higher spatial resolution in the through-plane direction would potentially lead to significant 
signal changes around the edges of such ROI due to interpolation. It is important in this context that 
the slice thickness of our T2 and FLAIR images is twice that in the data from Dr Huppertz. 
Other factors contributing to the difference of the results, such as different cohorts of patients and 
use of a different scanner, may also contribute to this difference. It is noteworthy that both the 
scatterplot (Figure 3b) and the analogues scatterplot [see Figure2 in Huppertz, 2011] show similarity in 
their inability to show clear quantitative limits of hippocampal nFSI measures between controls and 
patients. In contrast, the T2 scatterplot illustrates existence of such quantitative limits. 
The T2 map is obtained based on two measurements (dual-echo sequence) whereas T2 FLAIR is based 
on one measurement. This is an inherent difference of the modalities, which leads to the T2 mapping 
technique to have twice the amount of data as the FLAIR and thus likely also a higher SNR. The 
performance of the nFSI method would improve with twice the sampling. However, the doubled 
sampling would increase the duration of the T2 FLAIR scan making it less practical clinically and more 
prone to the motion artefact. 
It remains to be determined whether nFSI may detect abnormalities in the small minority of cases with 
sclerotic hippocampi in which T2 mapping is within the normal range. 
 
Conclusion 
 
T2 mapping remains the technique of choice for differentiation of the patients with HS from healthy 
subjects when applying the criterion of T2 signal intensity. 
There is a high degree of confidence that this conclusion will persist even with advances with 
neuroimaging equipment and introduction of diagnostic T2 images with resolution at the level of 
1mm
3 isotropic. 
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Table 1. Characteristics of the patient group (n=27) 
Characteristic  Value 
Age at scanning, yr (median (range))  32 (18-52) 
Age at onset of epilepsy, yr (median (range))  11 (1-32) 
Duration of epilepsy at the time of scan, yr (median (range))  19 (6-46) 
No of complex partial seizures per month in year prior to scan  (median (range))  8 (1-900) 
No of patients with habitual secondarily generalized tonic clonic seizures  13 
No of patients with early childhood convulsion   13 
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  A  B 
Figure 1. Placement of ovoid ROIs on hippocampal slices of T2 map (A) and T2 FLAIR (B) images 
[Bartlett PA, et al, 2007]. 
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Figure 2. Comparison of T2 and nFSI values for separation of healthy-vs-sclerotic hippocampi. 
Horizontal axis – T2 values; vertical axis – nFSI values. The red dashed lines, defined as mean + 2SD, 
separate measurements for the hippocampi of the healthy controls. 
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  A  B 
Figure 3. The comparison of T2 (A) and nFSI (B) values for lateralisation of the HS and separation 
controls-vs-patients. The red dashed lines, defined as mean + 2SD, separate measurements for the 
hippocampi of the healthy controls. 